摘要
近年来,越来越多的研究表明中性粒细胞血小板(NPS)评分对癌症患者的预后评估具有重要的临床意义。改良的中性粒细胞血小板评分(mNPS)作为反应机体预后的重要参数,已被报道用于多种类型癌症的预后。本文主要就mNPS对评估癌症患者预后的临床价值做一综述。
In recent years, an increasing number of studies have shown that the neutrophil platelet (NPS) score has important clinical significance in evaluating the prognosis of cancer patients. The im-proved neutrophil platelet score (mNPS), as an important parameter reflecting the prognosis of the body, has been reported for the prognosis of various types of cancer. This article mainly reviews the clinical value of mNPS in evaluating the prognosis of cancer patients.
出处
《临床医学进展》
2023年第12期18775-18779,共5页
Advances in Clinical Medicine